Cash Flow Statement
Growth Metrics

Elevance Health (ELV) Gross Profit (2016 - 2025)

Elevance Health (ELV) has disclosed Gross Profit for 17 consecutive years, with $43.8 billion as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 266.68% to $43.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $146.8 billion through Dec 2025, up 54.5% year-over-year, with the annual reading at $176.4 billion for FY2025, 256.78% up from the prior year.
  • Gross Profit for Q4 2025 was $43.8 billion at Elevance Health, down from $45.3 billion in the prior quarter.
  • The five-year high for Gross Profit was $45.3 billion in Q3 2025, with the low at -$68.3 billion in Q4 2023.
  • Average Gross Profit over 5 years is $18.6 billion, with a median of $13.2 billion recorded in 2022.
  • The sharpest move saw Gross Profit soared 296.38% in 2021, then crashed 628.68% in 2023.
  • Over 5 years, Gross Profit stood at $27.7 billion in 2021, then tumbled by 53.37% to $12.9 billion in 2022, then plummeted by 628.68% to -$68.3 billion in 2023, then surged by 117.49% to $11.9 billion in 2024, then soared by 266.68% to $43.8 billion in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $43.8 billion, $45.3 billion, and $44.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.